Ischemic preconditioning specifically restores complexes I and II activities of the mitochondrial respiratory chain in ischemic skeletal muscle

Journal of Vascular Surgery

Volumn 46, Issue 3, 2007, Pages 541-547

  Thaveau, Fabien ^a   Zoll, Joffrey ^b   Rouyer, Olivier ^b   Chafke, Nabil ^a   Kretz, Jean Georges ^a   Piquard, Francois ^b   Geny, Bernard ^b  

^a HÔPITAL CIVIL   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; GLUTAMIC ACID; MALEIC ACID; MITOCHONDRIAL ENZYME; SUCCINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON TRANSPORT; GASTROCNEMIUS MUSCLE; GENERAL ANESTHESIA; ISCHEMIC PRECONDITIONING; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE ISCHEMIA; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; RESPIRATORY CHAIN; SKELETAL MUSCLE; TOURNIQUET;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX II; ISCHEMIA; ISCHEMIC PRECONDITIONING; MALE; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; OXIDATIVE STRESS; PROGNOSIS; RATS; RATS, WISTAR;

EID: 34548437498     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.04.075     Document Type: Article

References (38)

1. Pang C.Y., Yang R.Z., Zhong A., Xu N., Boyd B., and Forrest C.R. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res 29 (1995) 782-788
2. Grisotto P.C., dos Santos A.C., Coutinho-Netto J., Cherri J., and Piccinato C.E. Indicators of oxidative injury and alterations of the cell membrane in the skeletal muscle of rats submitted to ischemia and reperfusion. J Surg Res 92 (2000) 1-6
3. Primeau A.J., Adhihetty P.J., and Hood D.A. Apoptosis in heart and skeletal muscle. Can J Appl Physiol 27 (2002) 349-395
4. Hallström S., Gasser H., Neumayer C., Fügl A., Nanobashvili J., Jakubowski A., et al. S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation 105 (2002) 3032-3038
5. Dion Y.M., Cardon A., Hartung O., and Gracia C.R. Laparoscopic aorto-iliac surgery: present status and future perspectives. Surg Technol Int 8 (2000) 201-207
6. Fearn S.J., Thaveau F., Kolvenbach R., and Dion Y.M. Minilaparotomy for aortoiliac aneurysmal disease: experience and review of the literature. Surg Laparosc Endosc Percutan Tech 15 (2005) 220-225
7. Coggia M., Javerliat I., Di Centa I., Alfonsi P., Colacchio G., Kitzis M., et al. Total laparoscopic versus abdominal aortic aneurysm repair: a case-control study. J Vasc Surg 42 (2005) 906-911
8. Khouri R.K., Cooley B.C., Kunselman A.R., Landis J.R., Yeramian P., Ingram D., et al. A prospective study of microvasculair free-flap surgery and outcome. Plast Reconstr Surg 102 (1998) 711-721
9. Küntscher M.V., Schirmbeck E.U., Menke H., Klar E., Gebhard M.M., and Germann G. Ischemic preconditioning by brief extremity schema before flap schema in a rat model. Plast Reconstr Surg 109 (2002) 2398-2404
10. Addison P.D., Neligan P.C., Ashrafpour H., Khan A., Zhong A., Moses M., et al. Noninvasive remote biochemici preconditioning for global protector of selecta muscle against infarction. Am J Physiol Heart Circ Physiol 285 (2003) H1435-H1443
11. Blaisdell F.W. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg 10 (2002) 620-630
12. Wallace D. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancers: a dawn for evolutionary medicine. Annu Rev Genet 39 (2005) 359-407
13. Brandao M.L., Roselino J.E., Piccinato C.E., and Cherri J. Mitochondrial alterations in skeletal muscle submitted to total ischemia. J Surg Res 110 (2003) 235-240
14. Pipinos I.I., Sharov V.G., Shepard A.D., Anagnostopoulos P.V., Katsamouris A., et al. Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease. J Vasc Surg 38 (2003) 827-832
15. Pipinos I.I., Judge A.R., Zhu Z., Selsby J.T., Swanson S.A., Johanning J.M., et al. Mitochondrial defects and oxidative damage in patients with peripheral arterial disease. Free Radic Biol Med 41 (2006) 262-269
16. Zoll J., Sanchez H., N'Guessan B., Ribera F., Lampert E., Bigard X., et al. Physical activity changes the regulation of mitochondrial respiration in human skeletal muscle. J Physiol 543 (2002) 191-200
17. Lagouge M., Argmann C., Gergart-Hines Z., Meziane H., Lerin C., Daussin F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 217 (2006) 1-14
18. Mounsey R.A., Pang C.Y., Boyd J.B., and Forrest C. Augmentation of skeletal muscle survival in the latissimus dorsi porcine model using acute ischemic preconditioning. J Otolaryngol 21 (1992) 315-320
19. Gurke L., Mattei A., Chaloupka K., Marx A., Sutter P.M., Stierli P., et al. Mechanisms of ischemic preconditioning in skeletal muscle. J Surg Res 94 (2000) 18-27
20. Saks V.A., Veksler V.I., Kuznetsov A.V., Kay L., Sikk P., Tiivel T., et al. Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol Cell Biochem 184 (1998) 81-100
21. N'Guessan B., Zoll J., Ribera F., Ponsot E., Lampert E., Ventura-Clapier R., et al. Evaluation of quantitative and qualitative aspects of mitochondrial function in human skeletal and cardiac muscles. Mol Cell Biochem 256-257 (2004) 267-280
22. Gnaiger E., Lassnig B., Kuznetsov A., Rieger G., and Margreiter R. Mitochondrial oxygen affinity, respiratory flux control and excess capacity of cytochrome c oxidase. J Exp Biol 201 (1998) 1129-1139
23. Zoll J., Monassier L., Garnier A., N'Guessan B., Mettauer B., Veksler V., et al. ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction. J Appl Physiol 101 (2006) 385-391
24. Lee S.S., Girod C., Valla D., Geoffroy P., and Lebrec D. Effects of pentobarbital sodium anesthesia on splanchnic hemodynamics of normal and portal-hypertensive rats. Am J Physiol 249 (1985) G528-G532
25. Zoll J., Ponsot E., Doutreleau S., Mettauer B., Piquard F., Mazzucotelli J.P., et al. Acute myocardial ischemia induces specific alterations of ventricular mitochondrial function in experimental pigs. Acta Physiol Scand 185 (2005) 25-32
26. Ljubkovic M., Mio Y., Marinovic J., Stadnicka A., Warltier D.C., Bosnjak Z.J., et al. Isoflurane preconditioning uncouples mitochondria and protects from hypoxia/reoxygenation. Am J Physiol Cell Physiol 292 (2007) C1583-C1590
27. Belkin M., Brown R.D., Wright J.G., LaMorte W.W., and Hobson R.W. A new quantitative spectrophotometric assay of ischemia-reperfusion injury in skeletal muscle. Am J Surg 156 (1988) 83-86
28. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
29. Banga N.R., Homer-Vanniasinkam S., Graham A., Al-Mukhtar A., White S.A., and Prasad K.R. Ischaemic preconditioning in transplantation and major resection of the liver. Br J Surg 92 (2005) 528-538
30. Jerome S.N., Akimitsu T., Gute D.C., and Korthuis R.J. Ischemic preconditioning attenuates capillary no-reflow induced by prolonged ischemia and reperfusion. Am J Physiol 268 (1995) 2063-2067
31. Akimitsu T., White J.A., Carden D.L., Gute D.C., and Korthuis R.J. Fructose-1,6-diphosphate or adenosine attenuate leukocyte adherence in postischemic skeletal muscle. Am J Physiol 269 (1995) 1743-1751
32. Gurke L., Marx A., Sutter P.M., Frentzel A., Harder F., Seelig J., et al. Ischemic preconditioning: a new concept in orthopedic and reconstructive surgery. J Surg Res 61 (1996) 1-3
33. Khardanba R.K., Peters M., Walton B., Kattenhorn M., Mullen M., Klein N., et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 103 (2001) 1624-1630
34. Kharbanda R.K., Li J., Konstantinov I.E., Cheung M.M., White P.A., Frndova H., et al. Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study. Heart 92 (2006) 1506-1511
35. Richter C., Gogvadze V., Laffranchi R., Schlapbach R., Schweizer M., Suter M., et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1271 (1995) 67-74
36. Zhang Y., Marcillat O., Giulivi C., Ernster L., and Davies K.J. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 265 (1990) 16330-16336
37. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., and Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278 (2003) 36027-36031
38. Brass E.P., and Hiatt W.R. Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease. Vasc Med 5 (2000) 55-59